-
The commercial funding of continuing medical education (CME) and the potential for bias is of great concern for a significant number of healthcare practitioners and researchers, many of whom admit to being unwilling to pay higher fees to eliminate or offset commercial funding, according to a report in the Archives of Internal Medicine, (Arch Intern Med 2011;171:840-846).
-
Ethical questions and concerns are being raised in cities and towns all over the United States as a number of prison inmates seem to be receiving better and/or reduced rate healthcare for otherwise costly medical procedures.
-
The first-in-human clinical trials raise difficult ethical issues for researchers and review boards because of the uncertainty that accompanies them.
-
While the possibility of using genetic information for evil, rather than good, sounds like something out of a science fiction movie, the likelihood of that happening is ever-present.
-
Large and state-of-the-art research organizations are proving that technological solutions can make every compliance effort more efficient and better documented.
-
Research coordinators and investigators sometimes fail to imagine all of the different types of institutional responsibilities that could be affected by a conflicts of interest (COI) policy.
-
The bottom line to better financial management of any clinical research (CR) site is the budget. Better budgets lead to better negotiating, staffing, and contracts. So it's a great place to start a quality improvement project.
-
It's difficult to imagine another industry that would tolerate six- to 18-month lag times on payments for services or products. Yet it has been a tradition in the clinical research (CR) industry.
-
-
Through evaluation programs, a research institution can learn what works and what doesn't in its quality improvement efforts.